
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 4 401-408, Copyright © 1995 by American Association for Cancer Research
ARTICLES |
TK Yun and SY Choi
Laboratory of Cancer Pathology, Korea Cancer Center Hospital, Seoul.
This study presents the risk of various cancers in relation to ginseng intake based on the data from a case-control study conducted in the Korea Cancer Center Hospital. Ginseng intakers had a decreased risk [odds ratio = 0.50, 95% confidence interval (CI) = 0.44-0.58] for cancer compared with nonintakers. On the type of ginseng, the odds ratios for cancer were 0.37 (95% CI = 0.29-0.46) for fresh ginseng extract intakers, 0.57 (95% CI = 0.48-0.68) for white ginseng extract intakers, 0.30 (95% CI = 0.22-0.41) for white ginseng powder intakers, and 0.20 (95% CI = 0.08-0.50) for red ginseng intakers. Intakers of fresh ginseng slice, fresh ginseng juice, and white ginseng tea, however, showed no decreasing risk. There was a decrease in risk with the rising frequency and duration of ginseng intake, showing a dose-response relationship. On the site of cancer, the odds ratios were 0.47 for cancer of the lip, oral cavity, and pharynx; 0.20 for esophageal cancer; 0.36 for stomach cancer; 0.42 for colorectal cancer; 0.48 for liver cancer; 0.22 for pancreatic cancer; 0.18 for laryngeal cancer; 0.55 for lung cancer; and 0.15 for ovarian cancer. In cancers of the female breast, uterine cervix, urinary bladder, and thyroid gland, however, there was no association with ginseng intake. In cancers of the lung, lip, oral cavity and pharynx, and liver, smokers with ginseng intake showed decreased odds ratios compared with smokers without ginseng intake. These findings support the view that ginseng intakers had a decreased risk for most cancers compared with nonintakers.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
F. Kamangar, Y.-T. Gao, X.-O. Shu, K. Kahkeshani, B.-T. Ji, G. Yang, H.-L. Li, N. Rothman, W.-H. Chow, and W. Zheng Ginseng Intake and Gastric Cancer Risk in the Shanghai Women's Health Study Cohort Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 629 - 630. [Full Text] [PDF] |
||||
![]() |
E. J. Small, M. W. Frohlich, R. Bok, K. Shinohara, G. Grossfeld, Z. Rozenblat, Wm. K. Kelly, M. Corry, and D. M. Reese Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer J. Clin. Oncol., November 1, 2000; 18(21): 3595 - 3603. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J Craig Health-promoting properties of common herbs Am. J. Clinical Nutrition, September 1, 1999; 70(3): 491S - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O'Hara, D. Kiefer, K. Farrell, and K. Kemper A Review of 12 Commonly Used Medicinal Herbs Arch Fam Med, November 1, 1998; 7(6): 523 - 536. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |